Answers are grounded in this paper and cite their sources.
Nicotine (NT) replacement therapy is a key strategy for smoking cessation, yet the instability and rapid degradation of NT limit the effectiveness of conventional delivery systems. In this study, we developed and characterized electrospun polyvinyl alcohol (PVA)–chitosan nanofibers (NFs) incorporating NT either directly or via amylose inclusion complexes (ICs) to enhance NT stability and enable its controlled release. NT was encapsulated in amylose, forming V-type crystalline structures as confirmed by X-ray diffraction; while scanning electron microscopy revealed tubular morphology indicative of successful IC formation. Fourier-transform infrared spectroscopy demonstrated hydrogen bonding and molecular interactions between NT and amylose, confirming encapsulation. Electrospun NFs exhibited smooth, bead-free morphologies for all formulations, with thicker and more variable fiber diameters observed in the amylose–NT-loaded samples, suggesting the presence of internal encapsulated domains. Thermogravimetric analysis showed that direct NT incorporation enhanced the thermal stability of PVA–chitosan NFs (T max ≈ 445 °C), while amylose-encapsulated NT provided moderate stabilization, highlighting a trade-off between thermal resilience and encapsulation. The nanofibrous mats offer high porosity and large surface area, suitable for fast-dissolving oral delivery, while the amylose-based IC supports controlled release and protection of NT against oxidation and thermal degradation. Overall, this work demonstrates that amylose-mediated encapsulation within electrospun PVA–chitosan NFs is a promising approach for stable, efficient NT delivery, providing insights for the design of advanced polysaccharide-based drug delivery systems.
No takes yet. Share an insight, caveat, or question.
Mokhtari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: